Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 293

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease

Spadaro, L., Magliocco, O., Spampinato, D., Piro, S., Oliveri, C., Alagona, C., Papa, G., Rabuazzo, A.M., Purrello, F.·2008·Digestive and Liver Disease
DOI 10.1016/j.dld.2007.10.003
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.dld.2007.10.003

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 27

  1. Bugianesi, 2005, Insulin resistance: a metabolic pathway to chronic liver disease, Hepatology, 42, 987, 10.1002/hep.20920 · DOI · Paper page
  2. McCullough, 2006, Pathophysiology of non-alcoholic steatohepatitis, J Clin Gastroenterol, 40, S17
  3. Clarke, 2001, Molecular mechanism for Polyunsaturated fatty acid regulation of gene transcription, Am J Physiol Gastrointest Liver Physiol, 281, G865, 10.1152/ajpgi.2001.281.4.G865 · DOI
  4. Krey, 1997, Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferatorsactivated receptors by coactivator-dependent receptor ligand assay, Mol Endocrinol, 11, 779, 10.1210/me.11.6.779 · doi:10.1210/me.11.6.779 · Paper page
  5. Calder, 2006, N-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases, Am J Clin Nutr, 83
  6. Svegliati-Baroni, 2006, A Model of insulin resistance and Nonalcoholic Steatohepatitis in Rats, Am J Pathol, 169
  7. Taouis, 2002, N-3 polyunsaturated fatty acids prevent the defect of insulin receptor signalling in muscle, Am J Physiol Endocrinol Metab, 282, E664, 10.1152/ajpendo.00320.2001 · DOI
  8. Capanni, 2006, Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study, Aliment Pharmacol Ther, 23, 1143, 10.1111/j.1365-2036.2006.02885.x · DOI · Paper page
  9. Nettleton, 2005, N-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review, Am Diet Assoc, 105, 428, 10.1016/j.jada.2004.11.029 · DOI · Paper page
  10. Krauss, 2000, AHA dietary guidelines: Revision 2000: a statement for Healthcare Professional from the Nutrition Committee of the American Heart Association, Circulation, 102, 2284, 10.1161/01.CIR.102.18.2284 · DOI · Paper page
  11. Saadeh, 2002, The utility of radiological imaging in non-alcoholic fatty liver disease, Gastroenterology, 123, 745, 10.1053/gast.2002.35354 · DOI · Paper page
  12. McCullough, 2006, Thiazolidinediones for nonalcoholic steatohepatitis. Promising but not ready for prime time, N Engl J Med, 355, 2361, 10.1056/NEJMe068232 · DOI
  13. Carpentier, 2006, n-3 Fatty acids and the metabolic syndrome, Am J Clin Nutr, 83
  14. Crespo, 2001, Gene expression of tumor necrosis factor alpha and TNF receptors, p55 and p75 in non-alcoholic steatohepatitis patients, Hepatology, 34, 1158, 10.1053/jhep.2001.29628 · DOI · Paper page
  15. Manco, 2007, Correlation of serum TNF-alpha levels and histologic liver injury scores in pediatric nonalcoholic fatty liver disease, Am J Clin Pathol, 127, 954, 10.1309/6VJ4DWGYDU0XYJ8Q · DOI
  16. Satapathy, 2004, Beneficial effects of tumor necrosis factor-a inhibition by pentoxifylline on clinical, biochemical and metabolic parameters of patients with nonalcoholic steatohepatitis, Am J Gastroenterol, 99, 1946, 10.1111/j.1572-0241.2004.40220.x · DOI
  17. Lee, 2007, Omega-3 fatty acids and liver disease, Hepatology, 45, 841, 10.1002/hep.21645 · DOI
  18. Calder, 2005, Polyunsaturated fatty acids and inflammation, Biochem Soc Trans, 33, 423, 10.1042/BST0330423 · DOI · Paper page
  19. Skuladottir, 2007, The effects of omega-3-polyunsaturated fatty acids on TNF-alpha and IL-10 secretion by murine peritoneal cells in vitro, Lipids, 42, 699, 10.1007/s11745-007-3081-1 · doi:10.1007/s11745-007-3081-1
  20. Combettes-Souverain, 1998, Molecular basis on insulin action, Diabetes Metab, 24, 477
  21. Shimomura, 2000, Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic an ob/ob mice, Mol Cell, 6, 77, 10.1016/S1097-2765(00)00009-5 · DOI · Paper page
  22. Shimomura, 1999, Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus, J Biol Chem, 274, 30028, 10.1074/jbc.274.42.30028 · DOI · Paper page
  23. Ip, 2004, Administration of the potent PPAR alpha agonist, Wyeth 14,643 reverses nutritional fibrosis and steatohepatitis in mice, Hepatology, 39, 1286, 10.1002/hep.20170 · DOI · Paper page
  24. Ip, 2003, Central role of PPARα-dependent hepatic lipid turnover in dietary steatohepatitis in mice, Hepatology, 38, 123, 10.1053/jhep.2003.50307 · DOI · Paper page
  25. Sanyal, 2002, AGA technical review on non-alcoholic fatty liver disease, Gastroenterology, 123, 1705, 10.1053/gast.2002.36572 · DOI · Paper page
  26. Ribeiro, 2004, Hepatocyte Apoptosis, expression of death receptors, and activation of NF-κB in the liver of non-alcoholic and alcoholic Steatohepatitis patients, Am J Gastroenterol, 99, 1708, 10.1111/j.1572-0241.2004.40009.x · DOI · Paper page
  27. Kim, 2005, Severity of ultrasonographic liver steatosis and metabolic syndrome in Korean men and women, World J Gastroenterol, 11, 5314, 10.3748/wjg.v11.i34.5314 · DOI

Cited by

See all 293

Metadata

Authors
Spadaro, L., Magliocco, O., Spampinato, D., Piro, S., Oliveri, C., Alagona, C., Papa, G., Rabuazzo, A. M., & Purrello, F.
Venue
Digestive and Liver Disease
Publisher
Elsevier BV
Published
2008-03
Volume
40
Issue
3
Pages
194-199
ISSN
1590-8658 (ISSN-L)
DOI
10.1016/j.dld.2007.10.003
OpenAlex
W2052981488
Cited by
293
References
6
FWCI
8.79
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.